The anti-EGFR AY13 mAb could represent a tool for the specific detection of EGFRhigh tumors, especially when combined with more tumor-specific antibodies in a simultaneous multicolor codetection approach, but this requires further investigation. This evidence concerns the gene EGFR and neoplasm.